These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 31450851)

  • 1. Therapeutic Effects of Botulinum Toxin A, via Urethral Sphincter Injection on Voiding Dysfunction Due to Different Bladder and Urethral Sphincter Dysfunctions.
    Lee YK; Kuo HC
    Toxins (Basel); 2019 Aug; 11(9):. PubMed ID: 31450851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Videourodynamic factors predictive of successful onabotulinumtoxinA urethral sphincter injection for neurogenic or non-neurogenic detrusor underactivity.
    Jiang YH; Jhang JF; Chen SF; Kuo HC
    Low Urin Tract Symptoms; 2019 Jan; 11(1):66-71. PubMed ID: 29024564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-World Data Regarding Satisfaction to Botulinum Toxin A Injection into the Urethral Sphincter and Further Bladder Management for Voiding Dysfunction among Patients with Spinal Cord Injury and Voiding Dysfunction.
    Lee CL; Jhang JF; Jiang YH; Kuo HC
    Toxins (Basel); 2022 Jan; 14(1):. PubMed ID: 35051007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic effect of urethral sphincter onabotulinumtoxinA injection for urethral sphincter hyperactivity.
    Jiang YH; Chen SF; Jhang JF; Kuo HC
    Neurourol Urodyn; 2018 Nov; 37(8):2651-2657. PubMed ID: 29797345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive Factors for the Successful Outcome of Urethral Sphincter Injections of Botulinum Toxin A for Non-Neurogenic Dysfunctional Voiding in Women.
    Yang CC; Jiang YH; Kuo HC
    Toxins (Basel); 2024 Sep; 16(9):. PubMed ID: 39330844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic Effects of Urethral Sphincter Botulinum Toxin A Injection on Dysfunctional Voiding with Different Videourodynamic Characteristics in Non-Neurogenic Women.
    Jiang YH; Lee CL; Chen SF; Kuo HC
    Toxins (Basel); 2021 May; 13(5):. PubMed ID: 34069448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive Factors for a Successful Treatment Outcome in Patients with Different Voiding Dysfunction Subtypes Who Received Urethral Sphincter Botulinum Injection.
    Kao YL; Ou YC; Tsai KJ; Kuo HC
    Toxins (Basel); 2022 Dec; 14(12):. PubMed ID: 36548774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real-Life Treatment Outcome of Botulinum Toxin A Injection on Overactive Bladder and Voiding Dysfunction in Patients with Central Nervous System Lesions.
    Jiang YH; Jhang JF; Chen SF; Kuo HC
    Toxins (Basel); 2024 Mar; 16(3):. PubMed ID: 38535789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic Efficacy of Urethral Sphincteric Botulinum Toxin Injections for Female Sphincter Dysfunctions and a Search for Predictive Factors.
    Ou YC; Huang KH; Jan HC; Kuo HC; Kao YL; Tsai KJ
    Toxins (Basel); 2021 Jun; 13(6):. PubMed ID: 34199493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of Urethral Sphincter Botulinum Toxin A Injection in Patients with Spinal Cord Injury with Dysuria: A Retrospective Cohort Study.
    Yu WR; Tian JH; Kuo HC
    Toxins (Basel); 2024 Jul; 16(8):. PubMed ID: 39195746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. OnabotulinumtoxinA Urethral Sphincter Injection as Treatment for Non-neurogenic Voiding Dysfunction - A Randomized, Double-Blind, Placebo-Controlled Study.
    Jiang YH; Wang CC; Kuo HC
    Sci Rep; 2016 Dec; 6():38905. PubMed ID: 27958325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic outcome and quality of life between urethral and detrusor botulinum toxin treatment for patients with spinal cord lesions and detrusor sphincter dyssynergia.
    Kuo HC
    Int J Clin Pract; 2013 Oct; 67(10):1044-9. PubMed ID: 24073977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Therapeutic Effects and Pathophysiology of Botulinum Toxin A on Voiding Dysfunction Due to Urethral Sphincter Dysfunction.
    Kao YL; Huang KH; Kuo HC; Ou YC
    Toxins (Basel); 2019 Dec; 11(12):. PubMed ID: 31847090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Videourodynamic changes of botulinum toxin A in patients with neurogenic bladder dysfunction (NBD) and idiopathic detrusor overactivity (IDO) refractory to drug treatment.
    Alloussi SH; Lang Ch; Eichel R; Al-Kaabneh A; Seibold J; Schwentner C; Alloussi S
    World J Urol; 2012 Jun; 30(3):367-73. PubMed ID: 21842216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinum A toxin urethral sphincter injection in children with nonneurogenic neurogenic bladder.
    Mokhless I; Gaafar S; Fouda K; Shafik M; Assem A
    J Urol; 2006 Oct; 176(4 Pt 2):1767-70; discussion 1770. PubMed ID: 16945643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urethral Sphincter Botulinum Toxin A Injection for Non-Spinal Cord Injured Patients with Voiding Dysfunction without Anatomical Obstructions: Which Patients Benefit Most?
    Chen SF; Kuo HC
    Toxins (Basel); 2023 Jan; 15(2):. PubMed ID: 36828402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results.
    Schurch B; Stöhrer M; Kramer G; Schmid DM; Gaul G; Hauri D
    J Urol; 2000 Sep; 164(3 Pt 1):692-7. PubMed ID: 10953127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-institution experience in 110 patients with botulinum toxin A injection into bladder or urethra.
    Smith CP; Nishiguchi J; O'Leary M; Yoshimura N; Chancellor MB
    Urology; 2005 Jan; 65(1):37-41. PubMed ID: 15667859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum toxin A injection to the external urethral sphincter for voiding dysfunction in females: A tertiary center experience.
    Nadeem M; Lindsay J; Pakzad M; Hamid R; Ockrim J; Greenwell T
    Neurourol Urodyn; 2022 Nov; 41(8):1793-1799. PubMed ID: 35979710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intradetrusor onabotulinumtoxinA injections for refractory neurogenic detrusor overactivity incontinence: do we need urodynamic investigation for outcome assessment?
    Koschorke M; Leitner L; Sadri H; Knüpfer SC; Mehnert U; Kessler TM
    BJU Int; 2017 Dec; 120(6):848-854. PubMed ID: 28771936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.